An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Yassel Ramos-Gómez et al.|New Biotechnology|2022Cited by 58
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Glay Chinea-Santiago et al.|medRxiv|2021Cited by 19
Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesisViviana Falcón, Nelson Acosta‐Rivero, Teresita Montero-González et al.|Archives of Virology|2023Cited by 12
CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19Gerardo Guillén, Estebán Martínez, Verena Muzio et al.|International Journal of Infectious Diseases|2023Cited by 7
The Effect of the Anti-Covid-19 Vaccine Abdala Dose Level and Dosing Interval in Rats and Cynomolgus MonkeysIngrid Rodrı́guez, Enrique V. Iglesias, Edith Suzarte-Portal et al.|SSRN Electronic Journal|2023Cited by 0